
Isha Salian
Isha Salian writes on deep learning, science and healthcare, among other topics, as part of NVIDIA's corporate communications team. She first joined the company as an intern in summer 2015. Isha has a journalism MA, as well as undergraduate degrees in communication and English, from Stanford. Outside of work she enjoys Indian classical dance, reading, Netflix, and discovering new places to eat.
Healthcare Headliners Put AI Under the Microscope at GTC
Two revolutions are meeting in the field of life sciences — the explosion of digital data and the rise of AI computing to help healthcare professionals make sense of it… Read Article
AI, Computational Advances Ring In New Era for Healthcare
We’re at a pivotal moment to unlock a new, AI-accelerated era of discovery and medicine, says Kimberly Powell, NVIDIA’s vice president of healthcare. Speaking today at the J.P. Morgan Healthcare… Read Article
Freeze the Day: How UCSF Researchers Clear Up Cryo-EM Images with GPUs
When photographers take long-exposure photos, they maximize the amount of light their camera sensors receive. The technique helps capture scenes like the night sky, but it introduces blurring in the… Read Article
NVIDIA Research Achieves AI Training Breakthrough Using Limited Datasets
NVIDIA Research’s latest AI model is a prodigy among generative adversarial networks. Using a fraction of the study material needed by a typical GAN, it can learn skills as complex… Read Article
Drug Discovery in the Age of COVID-19
Drug discovery is like searching for the right jigsaw tile — in a puzzle box with 1060 molecular-size pieces. AI and HPC tools help researchers more quickly narrow down the… Read Article
Telltale Signs: AI Researchers Trace Cancer Risk Factors Using Tumor DNA
Life choices can change a person’s DNA — literally. Gene changes that occur in human cells over a person’s lifetime, known as somatic mutations, cause the vast majority of cancers…. Read Article
Screening for COVID-19: Japanese Startup Uses AI for Drug Discovery
Researchers are racing to discover the right drug molecule to treat COVID-19 — but the number of potential drug-like molecules out there is estimated to be an inconceivable 1060. “Even… Read Article
Into the Woods: AI Startup Lets Foresters See the Wood for the Trees
AI startup Trefos is helping foresters see the wood for the trees. Using custom lidar and camera-mounted drones, the Philadelphia-based company collects data for high-resolution, 3D forest maps. These metrics… Read Article
Qure.ai Helps Clinicians Answer Questions from COVID-19 Lung Scans
Qure.ai, a Mumbai-based startup, has been developing AI tools to detect signs of disease from lung scans since 2016. So when COVID-19 began spreading worldwide, the company raced to retool… Read Article